Company
Amgen
Amgen is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.
Latest on Amgen
- 13F: Paragon Capital Management holds Amgen ($1M)
- 13F: Fell Capital Management Adv holds Amgen ($2M)
- 13F: Kaydan Wealth Management holds Amgen ($673,994)
- 13F: Paladin Partners Llc holds Amgen ($784,009)
- Wikidata: Amgen — located in — United States
- Wikidata: Amgen — operates in — pharmaceutical industry
- Wikidata: Amgen — capital ownership — Amgen (Netherlands)
- Wikidata: Amgen — capital ownership — Amgen (Canada)
- Wikidata: Amgen — capital ownership — Amgen (Germany)
- Wikidata: Amgen — capital ownership — Amgen (France)
- 13F: Tompkins Financial holds Amgen ($19M)
- 13F: Coastline Trust holds Amgen ($7M)
Connections
20 entities linked to Amgen across the news graph.
Also connected to (20)
United Statespharmaceutical industryAmgen (Netherlands)Amgen (Canada)Amgen (Germany)Amgen (France)Palogic Value Management L PWillow Creek Capital ManagementFell Capital Management AdvPaladin Partners LlcCoastline TrustParagon Capital ManagementKaydan Wealth ManagementTompkins FinancialSTAT+: Can buying a drug patent application be seen as a bid to prolong a monopoly?FTC Files Amicus Brief to Protect Competition in Biologic Drug MarketsDrugmaker Amgen discloses data breach involving patient health informationSTAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and moreSTAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drugSTAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more